R2U-Tox Assay and EBiSC Joint Venture

The EIT Health project R2U Tox Assay and EBiSC2 joint venture. R2U Tox Assay focusses on revolutionising drug development by making toxicity testing more human. More information can be found on https://eithealth.eu/product-service/r2u-tox-assay/. EBiSC supports this EIT Health initiative by linking to the Ready-to-use cell models for screening developed by R2U Tox Assay.